Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilmLi, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infectionsYang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound HealingZhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effectorLin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathwaysShan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1αWang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious OsteomyelitisLe, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 UbiquitinationChen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger OsteomyelitisZhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptorWu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Dr Mohammadamin Parsaei, Maternal, Fetal & Neonatal Research Center, Iran

Dr. Mohammadamin Parsaei is a prominent academic and researcher specializing in [specific field]. He holds a [degree] from [institution] and has extensive experience in [area of expertise]. Dr. Parsaei is known for his contributions to [specific research focus or project], with numerous publications and impactful research outcomes. He is currently affiliated with [institution] as a [position], where he continues to advance knowledge in [field]. His work is widely recognized for its innovation and excellence. 📚🔬

Publication profile

google scholar

Education

Dr. Mohammadamin Parsaei earned their Doctor of Medicine degree from Tehran University of Medical Sciences in 2023, with a GPA of 3.68/4. Their thesis, titled “Assessing Clinical Outcomes of Adrenalectomy and Associated Factors: A Retrospective Study in Iran,” was successfully defended before the General Surgery faculty at Dr. Shariati Hospital, Tehran University of Medical Sciences. This research delves into the clinical outcomes of adrenalectomy procedures and explores the associated factors affecting patient outcomes in Iran. 🏥📚👩‍⚕️

Experience

Dr. Mohammadamin Parsaei is a Postdoctoral Research Fellow at the Maternal, Fetal & Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences (2023-present). In this role, Dr. Mohammadamin Parsaei conducts clinical trials, observational studies, and reviews in Obstetrics and Gynecology, Infertility, and Maternal-Fetal research. Responsibilities include statistical analysis, overseeing research projects, crafting proposals, and managing article submissions. Additionally, Dr. [Name] serves as a Research Supervisor at ResearchPlus Academy (2024-present) and NCWEB Association (2023-present), leading systematic reviews and meta-analyses in multidisciplinary fields and neuroradiology. 🧪📊🔬

Research focus

The research of M. Parsaei predominantly focuses on psychiatric and psychological disorders, neuroimaging, and reproductive health. Key areas include the efficacy and safety of psychiatric medications, the impact of neuroimaging on mental health conditions like schizophrenia and social anxiety disorders, and the role of various interventions in managing these conditions. Parsaei’s work also extends to evaluating treatments for reproductive health issues, such as ectopic pregnancies, and the effects of maternal obesity on offspring brain development. This diverse research contributes to understanding and improving mental health, neuroimaging techniques, and reproductive outcomes. 🧠🔬💊👶

Publication top notes

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

Classification of suicidality by training supervised machine learning models with brain MRI findings: A systematic review

White matter alterations in affective and non-affective early psychosis: A diffusion MRI study

Methotrexate as the first-line treatment of unruptured tubular ectopic pregnancies with high initial human chorionic gonadotropin levels: A retrospective cohort

Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review

Microstructural white matter alterations associated with social anxiety disorders: A systematic review

Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial

Machine Learning for Prediction of Violent Behaviors in Schizophrenia Spectrum Disorders: A Systematic Review

White matter correlates of impulsive behavior in healthy individuals: A diffusion MRI study

Predicting the Outcomes of In Vitro Fertilization Using Baseline Maternal Serum Inflammatory Markers: A Retrospective Cohort Study